|
XIST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.382010E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.440100E-02 |
| Normal-vs-Stage2 |
6.300400E-03 |
| Normal-vs-Stage3 |
3.744900E-03 |
| Normal-vs-Stage4 |
2.628400E-04 |
| Stage1-vs-Stage2 |
5.104100E-02 |
| Stage1-vs-Stage3 |
1.651650E-02 |
| Stage1-vs-Stage4 |
6.027600E-04 |
| Stage2-vs-Stage3 |
9.785600E-01 |
| Stage2-vs-Stage4 |
1.921980E-01 |
| Stage3-vs-Stage4 |
1.339600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.816460E-02 |
| Normal-vs-AfricanAmerican |
4.963700E-02 |
| Normal-vs-Asian |
2.397000E-01 |
| Caucasian-vs-AfricanAmerican |
8.688600E-01 |
| Caucasian-vs-Asian |
2.614400E-01 |
| AfricanAmerican-vs-Asian |
3.784000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02720054684369E-11 |
| Normal-vs-Female |
6.404400E-01 |
| Male-vs-Female |
<1E-12 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.275900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.725700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.245200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.59160000004588E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.608800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.956000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.449960E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.160200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.212700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.776000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.365800E-01 |
| Classical-VS-Follicular |
8.344400E-01 |
| Classical-VS-Other |
3.367800E-01 |
| Classical-VS-Normal |
2.290500E-02 |
| Tall-VS-Follicular |
3.543000E-01 |
| Tall-VS-Other |
5.502200E-01 |
| Tall-VS-Normal |
1.196410E-02 |
| Follicular-VS-Other |
3.602600E-01 |
| Follicular-VS-Normal |
4.006000E-02 |
| Other-VS-Normal |
1.172650E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.332200E-02 |
| Normal-vs-N1 |
4.385200E-01 |
| N0-vs-N1 |
1.837820E-01 |
|
|
